Breast cancer
Results
Phase 2
This trial looked at lapatinib, trastuzumab and chemotherapy before surgery for breast cancer. The trial was for women who have HER2 positive breast cancer. This means the cancer has large amounts of a protein called .
If your breast cancer has spread into the surrounding tissue (is ), is inflammatory breast cancer or you have a large tumour, you may have chemotherapy before surgery. If your breast cancer is also HER2 positive you may have trastuzumab (Herceptin) before surgery.
Although this works well doctors are always looking for ways to improve treatment.
Recruitment start: 1 May 2011
Recruitment end: 31 January 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof David Cameron
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Last reviewed: 07 Oct 2015
CRUK internal database number: 9380